HCN News Team – Page 59 – Highly Capitalized

Wednesday, March 25, 2026 We Follow The Money.

About HCN News Team

The News Team at Highly Capitalized are some of the most experienced writers in cannabis and psychedelics business & finance. We cover capital markets, finance, branding, marketing and everything important in between. Most of all, we follow the money.

Compass Pathways’ Psilocybin-Based Therapy Reaches Key Milestone in Depression Trial

HCN News Team2025-06-26T10:48:12-08:00June 26th, 2025|Psychedelics|

LOS ANGELES- Compass Pathways has announced that its lead candidate, ...

Analysis: What’s Next for Texas THC Policy After Gov. Abbott’s Veto?

HCN News Team2025-06-25T11:01:55-08:00June 25th, 2025|Business|

DALLAS - In a move that stunned the Texas political ...

Maryland Governor Expands Cannabis Pardons

HCN News Team2025-06-25T07:13:37-08:00June 25th, 2025|Justice|

LOS ANGELES- Maryland Governor Wes Moore has announced an additional ...

Verano Taps Arizona Partner to Introduce Grow Sciences’ Cannabis Line in Illinois

HCN News Team2025-06-25T07:12:37-08:00June 25th, 2025|Business|

LOS ANGELES- Verano Holdings Corp. a vertically integrated multi-state cannabis ...

Court Reverses Health Canada’s Ban on Psilocybin Training for Clinicians

HCN News Team2025-06-25T07:06:44-08:00June 25th, 2025|Psychedelics|

LOS ANGELES- A recent decision by the Federal Court of ...

Minnesota Enacts Law Enhancing Employment Protections for Medical Cannabis Patients

HCN News Team2025-06-24T07:56:12-08:00June 24th, 2025|Insights|

LOS ANGELES— A new Minnesota law, Senate File 2370 (SF ...

Legal Cannabis Shows Economic Gains and Stable Teen Use Trends

HCN News Team2025-06-24T07:43:48-08:00June 24th, 2025|Justice|

LOS ANGELES— A recent analysis from the Marijuana Policy Project ...

High-Potency Cannabis Strains Impact Legal and Health Systems

HCN News Team2025-06-24T07:38:12-08:00June 24th, 2025|Business|

LOS ANGELES— The expansion of high-potency cannabis products—such as concentrated ...

New Zealand Approves Psilocybin for Medicinal Use

HCN News Team2025-06-23T08:55:25-08:00June 23rd, 2025|World|

LOS ANGELES— New Zealand’s government has authorized the prescription of psilocybin, ...

Psyence Group Inc. Announces C$600,000 Private Share Offering

HCN News Team2025-06-23T08:54:06-08:00June 23rd, 2025|Capital|

LOS ANGELES— Psyence Group Inc. a biotechnology firm focused on ...

Previous 585960 Next

DISCLAIMER NOTE: This email should be considered strictly private and confidential. Sender of this email is not a United States Securities Dealer, nor Broker, nor U.S. Investment Adviser. Sender is a Registered Corporation and Consultant, and makes no warranties, nor representations as to the buyer, seller, or transaction. Furthermore, this email includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended (the “Securities Act”), and Section 21E of the Securities Exchange Act of 1934, as amended (the “Exchange Act”). Read more

HCN Media Group | 171 Pier Avenue, Suite 177, Santa Monica, California, 90405

© Copyright | Highly Capitalized | All Rights Reserved | Website by Vadimages.